Bionyra Pharma
PrivateLast Round
Series A
Jun 22, 2026
Total Funding Raised
$165M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for immune-mediated inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionyra Pharma Comps
Public and private peers based on sector, stage, and business model.
Bionyra Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 22, 2026 | ||||
| Seed | Aug 1, 2025 |
Bionyra Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sixty Degree Capital | Series A |
| VIVES Partners | Series A |
| Sanofi Ventures | Series A |
| Sofinnova Partners | Series A, Seed |
| Arkin Bio Ventures | Series A |
| Jeito | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
$165M round led by Jeito and Sofinnova Partners.
- Aug 1, 2025
Raised a Seed round led by Sofinnova Partners.
Bionyra Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bionyra Pharma's valuation, stock price, and market status.
